$PFE PFIZER REPORTS SECOND-QUARTER 2021 RESULTS

on July 28, 2021 News and Tags: , , , with 0 comments
Time:
6:45 AM
Symbol:
PFE
Source:
Business Wire News Releases
Read more

$BNTX Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

on July 23, 2021 News and Tags: , , , , , , , with 0 comments
Time:
6:45 AM
Symbol:
BNTX
Source:
GlobeNewswire News Releases
Read more

$BNTX Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

on July 23, 2021 News and Tags: , , , , , , , with 0 comments
Time:
6:45 AM
Symbol:
BNTX
Source:
Business Wire News Releases
Read more

$ARVN Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471

on July 22, 2021 News and Tags: , , , , , , , with 0 comments
Time:
7:00 AM
Symbol:
ARVN
Source:
GlobeNewswire News Releases
Read more

$PFE Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings

on July 21, 2021 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
PFE
Source:
Business Wire News Releases
Read more

$BNTX Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa

on July 21, 2021 News and Tags: , , , , , , , with 0 comments
Time:
7:15 AM
Symbol:
BNTX
Source:
GlobeNewswire News Releases
Read more

$BNTX Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa

on July 21, 2021 News and Tags: , , , , , , , with 0 comments
Time:
7:15 AM
Symbol:
BNTX
Source:
Business Wire News Releases
Read more

$PFE Pfizer Announces New Investor Relations Leader

on July 19, 2021 News and Tags: , , , with 0 comments
Time:
6:45 AM
Symbol:
PFE
Source:
Business Wire News Releases
Read more

$PFE Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate

on July 19, 2021 News and Tags: , , , , , , , with 0 comments
Time:
1:00 AM
Symbol:
PFE
Source:
GlobeNewswire News Releases
Read more

$PFE Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate

on July 18, 2021 News and Tags: , , , , , , , with 0 comments
Time:
1:00 AM
Symbol:
PFE
Source:
GlobeNewswire News Releases
Read more

$PFE ViiV Healthcare presents data from second Dovato (dolutegravir/lamivudine) switch study confirming non-inferior efficacy and no virologic failure versus a broad range of regimens of at least 3 drugs

on July 17, 2021 News and Tags: , , , with 0 comments
Time:
6:06 AM
Symbol:
PFE
Source:
Business Wire News Releases
Read more

$PFE ViiV Healthcare study shows new long-acting HIV regimen Cabenuva (cabotegravir/rilpivirine) can be successfully implemented in broad range of US healthcare practices, even during COVID-19

on July 17, 2021 News and Tags: , , , with 0 comments
Time:
6:06 AM
Symbol:
PFE
Source:
Business Wire News Releases
Read more

$ABBV Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease

on July 8, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
4:06 PM
Symbol:
ABBV
Source:
GlobeNewswire News Releases
Read more

$PFE Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories

on July 5, 2021 News and Tags: , , , , , , , with 0 comments
Time:
6:04 AM
Symbol:
PFE
Source:
PR Newswire
Read more

$AGEN Eyes Shift to the Healthcare Industry After the Pandemic Prompts a Reconsideration

on July 2, 2021 News and Tags: , , , , , , , , , , , , , , , with 0 comments
Time:
9:00 AM
Symbol:
AGEN
Source:
PR Newswire
Read more

$PFE Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206

on June 30, 2021 News and Tags: , , , , , , , with 0 comments
Time:
6:46 PM
Symbol:
PFE
Source:
GlobeNewswire News Releases
Read more

$PFE Transgene: First Patient Enrolled in Expanded Phase II Clinical Trial of TG4001 + Avelumab Vs Avelumab Alone in Patients With HPV16-positive Anogenital Cancers

on June 24, 2021 News and Tags: , , , with 0 comments
Time:
11:45 AM
Symbol:
PFE
Source:
Business Wire News Releases
Read more

$PFE First Participant Dosed in Pfizer’s Pivotal Phase 3 TALAPRO-3 Combination Study of Talazoparib and Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

on June 23, 2021 News and Tags: , , , with 0 comments
Time:
6:45 AM
Symbol:
PFE
Source:
Business Wire News Releases
Read more

$GSK ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of “ultra-long-acting” medicines for HIV

on June 22, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
2:18 AM
Symbol:
GSK
Source:
PR Newswire
Read more

$GSK ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of “ultra long-acting” medicines for HIV

on June 22, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
2:22 AM
Symbol:
GSK
Source:
Business Wire News Releases
Read more